Pharmaceutical trade marks and parallel imports
Produced in partnership with Oscar Benito of Gavi, the Vaccines Alliance

The following Life Sciences practice note produced in partnership with Oscar Benito of Gavi, the Vaccines Alliance provides comprehensive and up to date legal information covering:

  • Pharmaceutical trade marks and parallel imports
  • Pharmaceutical trade marks: regulation and naming procedures
  • Marketing authorisations
  • National routes
  • International routes (collaborative procedures)
  • Regulatory guidelines for branding pharmaceutical products
  • International Nonproprietary Names (INNs), British Approved Names (BANs)
  • Umbrella products
  • Trade mark selection process and timing
  • Legal clearance searches
  • More...

Pharmaceutical trade marks and parallel imports

At 11 pm on 31 December 2020 (IP completion day), the UK ceased to be subject to EU law. The UK’s relationship with the EU is now governed by the Trade and Cooperation Agreement and the European Union (Future Relationship) Act 2020. However, in accordance with the European Union (Withdrawal) Act 2018, the UK retains a great deal of EU law as part of its domestic law. For further information, see Practice Note: Introduction to retained EU law.

From IP completion day, as a third country, the UK can no longer participate in the EU’s political institutions, agencies, offices, bodies, and it is no longer subject to EU law and the jurisdiction of the Court of Justice of the European Union. This Practice Note contains references to case law of the Court of Justice. Broadly, EU judgments handed down on or before 31 December 2020 continue to be binding on UK courts and tribunals (even if the EU courts later depart from them) until the UK courts exercise their powers to diverge. For information about the impact of Brexit on the life sciences sector, see Practice Note: What does IP completion day mean for Life Sciences?

On IP completion day, the UK ceased to be part of the EU trade mark (EUTM) regime. However, holders of existing EUTMs were granted equivalent

Popular documents